Fluconazole-induced acute generalized exanthematous pustulosis
- PMID: 25814733
- PMCID: PMC4372937
- DOI: 10.4103/0019-5154.152572
Fluconazole-induced acute generalized exanthematous pustulosis
Abstract
Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction and is usually caused by drugs. It is characterized by fever and acute, extensive occurrence of disseminated sterile pustules, accompanied by fever, malaise and peripheral blood leucocytosis. There have been several reports to date of AGEP following exposure to antifungals. In particular, terbinafine is included in the list of the agents conferring the highest risk of AGEP. The authors report the case of a 70-year-old male patient who developed AGEP shortly after commencing treatment with fluconazole, which has been reported in association with AGEP in a single case report. To our knowledge, this is the first reported case of AGEP associated with positive fluconazole patch test.
Keywords: Antifungals; drug; patch test; reaction; skin.
Conflict of interest statement
Figures



Similar articles
-
Fluconazole-induced acute generalized exanthematous pustulosis.Am J Emerg Med. 2021 Jan;39:254.e5-254.e7. doi: 10.1016/j.ajem.2020.06.061. Epub 2020 Jun 28. Am J Emerg Med. 2021. PMID: 32641264
-
Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.Int J Dermatol. 2010 May;49(5):507-12. doi: 10.1111/j.1365-4632.2010.04313.x. Int J Dermatol. 2010. PMID: 20534083
-
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.J Cutan Med Surg. 2013 Nov-Dec;17(6):414-8. doi: 10.2310/7750.2013.12105. J Cutan Med Surg. 2013. PMID: 24138979 Review.
-
Terbinafine Induced Acute Generalized Exanthematous Pustulosis Treated with Adalimumab: Recalcitrant to Systemic Corticosteroid Therapy.Clin Cosmet Investig Dermatol. 2023 Jan 4;16:9-15. doi: 10.2147/CCID.S391979. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 36619159 Free PMC article.
-
Acute generalised exanthematous pustulosis.Australas J Dermatol. 2012 May;53(2):87-92. doi: 10.1111/j.1440-0960.2011.00845.x. Epub 2011 Dec 29. Australas J Dermatol. 2012. PMID: 22571555 Review.
Cited by
-
Acute Generalised Exanthematous Pustulosis: An Update.Indian J Dermatol. 2018 Jan-Feb;63(1):22-29. doi: 10.4103/ijd.IJD_581_17. Indian J Dermatol. 2018. PMID: 29527022 Free PMC article.
-
Acute generalized exanthematous pustulosis with airway mucosa involvement: A case report.World J Clin Cases. 2020 Aug 26;8(16):3578-3582. doi: 10.12998/wjcc.v8.i16.3578. World J Clin Cases. 2020. PMID: 32913867 Free PMC article.
-
Multisystem organ failure secondary to acute generalised exanthematous pustulosis (AGEP) with atypical presentation resembling septic shock.BMJ Case Rep. 2022 Mar 1;15(3):e247040. doi: 10.1136/bcr-2021-247040. BMJ Case Rep. 2022. PMID: 35232738 Free PMC article.
References
-
- Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases) Ann Dermatol Venéol. 1980;107:37–48. - PubMed
-
- Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991;127:1333–8. - PubMed
-
- Di Lernia V, Grenzi L, Guareschi E, Ricci C. Rapid clearing of acute generalized exanthematous pustulosis after administration of ciclosporin. Clin Exp Dermatol. 2009;34:e757–9. - PubMed
-
- Gencoglan G, Tosun M, Aktepe F. The molecular mechanism of etanercept, an anti-tumour necrosis factor-alpha receptor-fusion protein, in the treatment of acute generalized exanthematous pustulosis. J Dermatolog Treat. 2009;20:241–5. - PubMed
-
- Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicenter study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168:555–62. - PubMed
LinkOut - more resources
Full Text Sources